Qilu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has twenty-eight approved drugs.
There is one tentative approval on QILU drugs.
Drugs and US Patents for Qilu
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Qilu Pharm Hainan | TADALAFIL | tadalafil | TABLET;ORAL | 210420-002 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Qilu | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 203661-002 | Mar 11, 2022 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Qilu Pharm Hainan | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 204890-001 | May 25, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Qilu | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 203661-003 | Jan 24, 2024 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Qilu | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 209333-001 | May 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-003 | Jun 29, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.